Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Allergen Source
3.3. Snippet by Treatment Type
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Prevalence of Allergies
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Cost of Treatment
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Type
6.1. Introduction
6.1.1. Market Type Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Seasonal Allergic Rhinitis *
6.2.1. Introduction
6.2.2. Market Type Analysis and Y-o-Y Growth Analysis (%)
6.3. Perennial Allergic Rhinitis
7. By Allergen Source
7.1. Introduction
7.1.1. Market Type Analysis and Y-o-Y Growth Analysis (%), By Allergen Source
7.1.2. Market Attractiveness Index, By Allergen Source
7.2. Pollen*
7.2.1. Introduction
7.2.2. Market Type Analysis and Y-o-Y Growth Analysis (%)
7.2.3. Tree pollen
7.2.4. Grass pollen
7.2.5. Weed pollen
7.3. Mold Spores
7.4. Dust Mites
8. By Treatment Type
8.1. Introduction
8.1.1. Market Type Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
8.1.2. Market Attractiveness Index, By Treatment Type
8.2. Immunotherapy*
8.2.1. Introduction
8.2.2. Market Type Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Subcutaneous Immunotherapy (SCIT)
8.2.4. Sublingual Immunotherapy (SLIT)
8.3. Drug Class
8.3.1. Antihistamines
8.3.2. Corticosteroids
8.3.3. Decongestants
8.3.4. Leukotriene Receptor Antagonists
8.3.5. Others
8.4. Homeopathy
8.5. Others
9. By End-User
9.1. Introduction
9.1.1. Market Type Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals & Specialty Clinics*
9.2.1. Introduction
9.2.2. Market Type Analysis and Y-o-Y Growth Analysis (%)
9.3. Homecare Settings
9.4. Homeopathy
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Type Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Type Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Type Analysis and Y-o-Y Growth Analysis (%), By Allergen Source
10.2.5. Market Type Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
10.2.6. Market Type Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.7. Market Type Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Type Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Type Analysis and Y-o-Y Growth Analysis (%), By Allergen Source
10.3.5. Market Type Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
10.3.6. Market Type Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.7. Market Type Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Spain
10.3.7.5. Italy
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Type Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Type Analysis and Y-o-Y Growth Analysis (%), By Allergen Source
10.4.5. Market Type Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
10.4.6. Market Type Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.7. Market Type Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Type Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Type Analysis and Y-o-Y Growth Analysis (%), By Allergen Source
10.5.5. Market Type Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
10.5.6. Market Type Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Type Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Type Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Type Analysis and Y-o-Y Growth Analysis (%), By Allergen Source
10.6.5. Market Type Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
10.6.6. Market Type Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. ALK-Abell? A/S *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. GSK plc
12.3. Sanofi
12.4. Merck & Co., Inc.
12.5. Johnson & Johnson Services, Inc.
12.6. Stallergenes Greer
12.7. Allergy Therapeutics
12.8. Teva Pharmaceutical Industries Ltd.
12.9. HAL Allergy B.V.
12.10. LETI Pharma
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us